During the past decade, Paratus Clinical Research - Western Sydney conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 1 clinical trials were completed, i.e. on average, 5.6% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 1 clinical trials were completed. i.e. 5.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Paratus Clinical Research - Western Sydney" #1 sponsor was "Novavax" with 3 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "ModernaTX, Inc." with 2 trials sponsored, "Actinogen Medical" with 1 trials sponsored and "BioAge Labs, Inc." with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Paratus Clinical Research - Western Sydney" #1 collaborator was "Avance Clinical" with 1 trials as a collaborator, "BioNet-Asia" with 1 trials as a collaborator, "Biocon Limited" with 1 trials as a collaborator, "Chulalongkorn University" with 1 trials as a collaborator and "Equillium AUS Pty Ltd" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Paratus Clinical Research - Western Sydney" are "COVID-19" (2 trials), "Respiratory Syncytial Virus" (2 trials), "Alzheimer's Disease" (1 trials), "Anemia" (1 trials) and "Asthma" (1 trials). Many other conditions were trialed in "Paratus Clinical Research - Western Sydney" in a lesser frequency.

Most popular intervention types in "Paratus Clinical Research - Western Sydney" are "Drug" (12 trials), "Biological" (6 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Tirzepatide" (2 trials), "1PC111" (1 trials), "A: OLP-1002" (1 trials) and "B: OLP-1002" (1 trials). Other intervention names were less common.

The vast majority of trials in "Paratus Clinical Research - Western Sydney" are 17 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Paratus Clinical Research - Western Sydney". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Paratus Clinical Research - Western Sydney, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Paratus Clinical Research - Western Sydney, 5 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".